"Real World Clinical Profile And Outcomes OfEndometrial Cancers From Tertiary Hospital From Northwest India.
试验速览
- 阶段
- 不适用
- 状态
- Not Applicable
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- CLINICOPATHOLOGICAL PROFILE , PROGRESSION FREE SURVIVAL AND OVERAL ALL SURVIVAL
研究概览
简要总结
Endometrial cancer is the most gynecological cancer diagnosed in the developed world, and most patients present in early stages. Post menopausal bleeding is the most common presentation and surgery is the mainstay of treatment. Survival outcomes are good but there is limited data from India , especially North west India.
Aims and objectives
1)To evaluate the clinicopathological profile of patients with carcinoma endometrium managed at tertiary cancer hospital Punjab.
2)To determine the progression free survival (PFS) and overall survival (OS) for patients with carcinoma endometrium.
Methods
Retrospective chart review will done from Mohandai Oswal hospital (MOH) for patients with biopsy proven carcinoma endometrium aged > 18 years , who have at least taken one modality of treatment from MOH. Data from electronic and paper bases would be collected from 1st January 2017 till 31st August 2022. The data would record and analysed statistically. Statistical analysis will be done using SPSS software version 22.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 75.00 Year(s)（—）
- 性别
- Female
入选标准
- •RETROSPECTIVE STUDY, ON PATIENTS TREATED AT THE CENTER.
排除标准
- •NON ENDOMETRIAL CANCERS, AGE LESS THAN
- •PATIENTS TREATED AT ANOTHER CENTER.
结局指标
主要结局
CLINICOPATHOLOGICAL PROFILE , PROGRESSION FREE SURVIVAL AND OVERAL ALL SURVIVAL
时间窗: BASELINE,12 MONTHS, 24 MONTHS, 36 MONTHS , 48 MONTHS AND 60 MONTHS
次要结局
- PROGRESSION FREE SURVIVAL AND OVERAL ALL SURVIVAL(BASELINE, 12 MONTHS, 24 MONTHS, 36 MONTHS, 48 MONTHS, 60 MONTHS)